UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer research (Chicago, Ill.), ISSN 0008-5472, 01/2008, Volume 68, Issue 2, pp. 521 - 529
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Neoplasm Transplantation | Prostatic Neoplasms - metabolism | Adenocarcinoma - pathology | Adenoviridae | Cell Proliferation | Humans | Male | Transplantation, Heterologous | Mammary Neoplasms, Experimental - metabolism | Vascular Endothelial Growth Factor A - genetics | Mammary Neoplasms, Experimental - genetics | Adenocarcinoma - metabolism | Prostatic Neoplasms - genetics | Mammary Neoplasms, Experimental - pathology | Female | Tumor Burden - genetics | Adenocarcinoma - genetics | Tumor Cells, Cultured | Prostatic Neoplasms - pathology | Transduction, Genetic | Mice, Inbred C57BL | Solubility | Vascular Endothelial Growth Factor Receptor-2 - blood | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Mice, Transgenic | Biomarkers, Tumor - blood | HT29 Cells | Animals | Mice | Mice, Inbred BALB C | Vascular Endothelial Growth Factor A - physiology | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 05/2005, Volume 65, Issue 10, pp. 4389 - 4400
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Corpus Luteum - drug effects | Corpus Luteum - growth & development | Humans | Quinazolines - pharmacokinetics | Biological Availability | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Extracellular Matrix Proteins | Female | Phosphorylation - drug effects | Protein Kinase Inhibitors - pharmacokinetics | Bone Development - drug effects | Administration, Oral | Endothelial Cells - metabolism | Neoplasms - enzymology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Neoplasms - blood supply | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Myosin Heavy Chains | Nonmuscle Myosin Type IIB | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Neoplasms - pathology | Quinazolines - pharmacology | Endothelial Cells - enzymology | Proteins - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-3 - antagonists & inhibitors | Endothelial Cells - drug effects | Index Medicus
Journal Article
Nature medicine, ISSN 1078-8956, 09/2009, Volume 15, Issue 9, pp. 1023 - 1030
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Animals, Newborn | Vascular Endothelial Growth Factor C - physiology | Alternative Splicing | Lymphatic Vessels - physiology | Humans | Mice, Inbred C57BL | Vascular Endothelial Growth Factor Receptor-2 - deficiency | DNA, Complementary - genetics | Lymphangiogenesis - physiology | Molecular Sequence Data | Vascular Endothelial Growth Factor Receptor-2 - genetics | Cornea - metabolism | Animals | Cornea - blood supply | Vascular Endothelial Growth Factor C - antagonists & inhibitors | Mice, Mutant Strains | Base Sequence | Mice | Mice, Inbred BALB C | Vascular Endothelial Growth Factor Receptor-2 - physiology | Lymphangiogenesis - genetics | Cornea - growth & development | Physiological aspects | Vascular endothelial growth factor | Research | Proteins | Signal transduction | Cell growth | Lymphatic system | Molecular biology | Rodents | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 06/2015, Volume 26, Issue 6, pp. 1230 - 1237
phase I study | ramucirumab | VEGFR-2 | vascular endothelial growth factor | solid tumors | Phase I study | Ramucirumab | Solid tumors | Vascular endothelial growth factor | Life Sciences & Biomedicine | Oncology | Science & Technology | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Vascular Endothelial Growth Factor Receptor-2 - immunology | Angiogenesis Inhibitors - blood | Antibodies, Monoclonal - blood | Antibodies, Monoclonal, Humanized | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Angiogenesis Inhibitors - administration & dosage | Neoplasms - blood | Adult | Female | Angiogenesis Inhibitors - adverse effects | Drug Administration Schedule | Vascular Endothelial Growth Factor A - blood | Antibodies, Monoclonal - pharmacokinetics | Neoplasms - enzymology | Vascular Endothelial Growth Factor Receptor-2 - blood | Treatment Outcome | Angiogenesis Inhibitors - pharmacokinetics | Disease Progression | Neoplasms - drug therapy | Biomarkers, Tumor - blood | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Neoplasms - immunology | Aged | Neoplasms - pathology | Vascular Endothelial Growth Factor Receptor-1 - blood | Index Medicus
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 11/2011, Volume 31, Issue 11, pp. 2595 - 2606
microRNAs | endothelium | angiogenesis | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Cardiology. Vascular system | Blood vessels and receptors | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Atherosclerosis (general aspects, experimental research) | Biological and medical sciences | Medical sciences | Vertebrates: cardiovascular system | Blood and lymphatic vessels | Endothelium, Vascular - cytology | Cell Proliferation | Humans | Cells, Cultured | Mice, SCID | Receptor, Fibroblast Growth Factor, Type 1 - physiology | Cell Movement - physiology | Endothelium, Vascular - physiology | Neovascularization, Physiologic - physiology | Animals | Cattle | Signal Transduction - physiology | Mice | Vascular Endothelial Growth Factor Receptor-2 - physiology | 3' Untranslated Regions - physiology | MicroRNAs - physiology | Vascular Endothelial Growth Factor A - physiology | Index Medicus
Journal Article
Molecular imaging and biology, ISSN 1536-1632, 2/2018, Volume 20, Issue 1, pp. 85 - 93
Molecular imaging | Vascular endothelial growth factor receptor (VEGFR) | Diabetes | Medicine & Public Health | Imaging / Radiology | Atherosclerosis | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Atherosclerosis - pathology | Diabetes Mellitus, Experimental - diagnosis | Apolipoproteins E - deficiency | Tomography, Emission-Computed, Single-Photon | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Atherosclerosis - complications | Male | Molecular Imaging - methods | Polyethylene Glycols - chemistry | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Apolipoproteins E - metabolism | Atherosclerosis - metabolism | Diabetes Mellitus, Experimental - blood | Tissue Distribution | Animals | Atherosclerosis - diagnosis | Diabetes Mellitus, Experimental - complications | Mice | Single-Chain Antibodies | Blood Glucose - metabolism | Diabetes Mellitus, Experimental - metabolism | Selectivity | Biology | Proteins | Angiogenesis | Receptors | Computed tomography | Apolipoprotein E | Polyethylene glycol | Imaging | Tomography | Aorta | Lesions | Vascular endothelial growth factor | Plaques | Photon emission | Medical imaging | Diabetes mellitus | Blood vessels | Single photon emission computed tomography | Mutants | Vascular endothelial growth factor receptors | Signaling | Computation | Arteriosclerosis | Coronary vessels | Tracers | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 780 - 787
Biological and medical sciences | Medical sciences | Tumors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Protein Kinase Inhibitors - adverse effects | Neovascularization, Pathologic - enzymology | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Angiogenesis Inhibitors - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Angiogenesis Inhibitors - adverse effects | Protein Kinase Inhibitors - pharmacokinetics | Vascular Endothelial Growth Factor A - blood | Antibodies, Monoclonal - pharmacokinetics | Neoplasms - enzymology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Neoplasms - blood supply | Treatment Outcome | Angiogenesis Inhibitors - pharmacokinetics | Neoplasms - drug therapy | Biomarkers, Tumor - blood | Magnetic Resonance Imaging | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Neovascularization, Pathologic - drug therapy | Protein Kinase Inhibitors - therapeutic use | Aged | Infusions, Intravenous | Vascular Endothelial Growth Factor Receptor-1 - blood | Index Medicus | Original Reports | Bone3 | Timg4 | Faze | To1
Journal Article
Journal of biochemistry and molecular biology, ISSN 1225-8687, 09/2006, Volume 39, Issue 5, pp. 469 - 478
VEGFR2 | VEGFR1 | Agiogenesis | VEGF-E | Macrophages | Tyrosine kinase receptor | Vascular endothelial growth factor | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Signal Transduction | Atherosclerosis - physiopathology | Humans | Neovascularization, Pathologic | Vascular Endothelial Growth Factor Receptor-1 - physiology | Embryonic Development - physiology | Neoplasms - blood supply | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor Receptor-1 - chemistry | Pre-Eclampsia - physiopathology | Viral Proteins - metabolism | Vascular Endothelial Growth Factor Receptor-2 - genetics | Pregnancy | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Animals | Neoplasm Metastasis - physiopathology | Female | Vascular Endothelial Growth Factor Receptor-2 - physiology | Neoplasms - physiopathology | Neovascularization, Physiologic | Inflammation - physiopathology | Vascular Endothelial Growth Factor Receptor-1 - genetics | Index Medicus
Journal Article
EMBO reports, ISSN 1469-221X, 11/2019, Volume 20, Issue 11, pp. e47845 - n/a
GRB2 | PI3Kp85 | proliferation | angiogenesis | Nck | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cell proliferation | Phosphorylation | Transcription | Gene regulation | Phosphotyrosine | AKT protein | Activation | Lethality | Myc protein | Kinases | Signal transduction | Pathways | Vascular endothelial growth factor | Growth factors | Tyrosine | Explants | Stability | Phenylalanine | Extracellular signal-regulated kinase | Blood vessels | Gene expression | Embryos | Endothelial cells | 1-Phosphatidylinositol 3-kinase | Grb2 protein | Signaling | Mutation | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 12/2013, Volume 19, Issue 23, pp. 6614 - 6623
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Liver Neoplasms - blood | Pregnancy Proteins - blood | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Carcinoma, Hepatocellular - drug therapy | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Hepatocellular - blood | Antibodies, Monoclonal - pharmacology | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Vascular Endothelial Growth Factor A - blood | Vascular Endothelial Growth Factor Receptor-2 - blood | Biomarkers, Tumor - blood | Disease-Free Survival | Placenta Growth Factor | Aged | Index Medicus
Journal Article